• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Georgia Integrates Prescription Drug Monitoring Programs with EHRs Statewide

by Fred Pennic 05/21/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Partners HealthCare Integrates MassPAT with Epic EHR to Curb Opioid Abuse

Appriss Health announced that Georgia is integrating its prescription drug monitoring programs into EHR systems of all prescribers across the state with Appriss Health’s PMP Gateway solution. This is being made possible by a Centers for Disease Control and Prevention grant – so all prescribers can instantly access prescription drug monitoring program (PDMP) information directly in the clinical workflow.

Substance use disorder (SUD) is estimated to affect 21 million people, according to a report by the US Surgeon General. With the opioid epidemic still a massive problem in the country, it is essential clinicians have all the tools they need for responsible and effective prescribing. 16 states, including Georgia, have aligned with Appriss Health to sponsor statewide adoption of PDMP integrations.

“Substance use disorder is a public health crisis in Georgia and all across the country,” said Rob Cohen, President, Appriss Health. “Working together with Georgia DPH to make the state’s PDMP efficiently accessible to all providers statewide enables them with the clinical decision support tools to truly help make an impact on this crisis.”

This is now making it easier for prescribers and pharmacists to access and use PDMP information, contributing to higher patient care and safety. Prior to this partnership, prescribers had to separately log into systems to access patient information. Appriss Health’s PMP Gateway is a managed service that enables access to PDMP information and more within real-time care team workflow, so prescribers can make informed decisions at the point of care.

Appriss Health is aligned with current legislative, grant funding, and government agency efforts to support the path forward for PDMPs and the identification, prevention, management, and treatment of SUD. Appriss Health has created and maintains a highly effective integration connectivity infrastructure designed to maximize the effectiveness and use of PDMP data and analytics within clinical workflows. This same infrastructure can accommodate rapid integration of the state PDMPs with clinical workflow for more than 80% of all prescribers and pharmacists nationwide.

Prescriber Reports

The Georgia Department of Public Health is also now utilizing Appriss Health’s Prescriber Reports. Prescriber Reports are intended to give prescribers insight into their opioid prescribing patterns through a series of defined metrics that will be provided to the individual on a quarterly basis. 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Appriss Health, Clinical Decision Support, clinical workflows, decision support, Opioid Epidemic, Opioid Prescriptions, Patient Care, point of care, Prescription Drug Monitoring Program, Prescription drug monitoring programs (PDMPs), Public Health

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |